Principal Financial Group Inc Eagle Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$25.06 - $34.09 $57,262 - $77,895	-2,285 Reduced 3.22%	68,620 $1.95 Million
Q4 2022 Feb 09, 2023	SELL	$24.98 - $39.77 $9,592 - $15,271	-384 Reduced 0.54%	70,905 $2.07 Million
Q3 2022 Nov 09, 2022	SELL	$26.42 - $47.12 $289,827 - $516,906	-10,970 Reduced 13.34%	71,289 $1.88 Million
Q2 2022 Aug 10, 2022	SELL	$41.26 - $51.35 $38,619 - $48,063	-936 Reduced 1.13%	82,259 $3.66 Million
Q1 2022 May 09, 2022	SELL	$44.58 - $52.6 $209,615 - $247,325	-4,702 Reduced 5.35%	83,195 $4.12 Million
Q4 2021 Feb 09, 2022	SELL	$45.82 - $56.9 $491,144 - $609,911	-10,719 Reduced 10.87%	87,897 $4.48 Million
Q3 2021 Nov 09, 2021	SELL	$43.79 - $55.78 $103,782 - $132,198	-2,370 Reduced 2.35%	98,616 $5.5 Million
Q2 2021 Aug 10, 2021	SELL	$36.86 - $44.5 $355,809 - $429,558	-9,653 Reduced 8.72%	100,986 $4.32 Million
Q1 2021 May 10, 2021	BUY	$40.32 - $50.97 $92,171 - $116,517	2,286 Added 2.11%	110,639 $4.62 Million
Q4 2020 Feb 08, 2021	BUY	$41.72 - $51.34 $42,637 - $52,469	1,022 Added 0.95%	108,353 $5.05 Million
Q3 2020 Nov 06, 2020	BUY	$37.02 - $51.28 $769,312 - $1.07 Million	20,781 Added 24.01%	107,331 $4.56 Million
Q2 2020 Aug 05, 2020	SELL	$43.24 - $55.02 $10,766 - $13,699	-249 Reduced 0.29%	86,550 $4.15 Million
Q1 2020 May 12, 2020	SELL	$34.37 - $60.07 $107,612 - $188,079	-3,131 Reduced 3.48%	86,799 $3.99 Million
Q4 2019 Feb 05, 2020	BUY	$54.32 - $64.31 $551,891 - $653,389	10,160 Added 12.74%	89,930 $5.4 Million
Q3 2019 Nov 13, 2019	SELL	$53.25 - $59.98 $152,774 - $172,082	-2,869 Reduced 3.47%	79,770 $4.51 Million
Q2 2019 Aug 12, 2019	SELL	$46.61 - $58.45 $7,550 - $9,468	-162 Reduced 0.2%	82,639 $4.6 Million
Q1 2019 May 10, 2019	SELL	$38.66 - $51.82 $250,826 - $336,208	-6,488 Reduced 7.27%	82,801 $4.18 Million
Q4 2018 Feb 14, 2019	SELL	$36.72 - $67.73 $24,565 - $45,311	-669 Reduced 0.74%	89,289 $3.6 Million
Q3 2018 Nov 14, 2018	BUY	$66.65 - $83.86 $1.67 Million - $2.11 Million	25,120 Added 38.74%	89,958 $6.24 Million
Q2 2018 Aug 13, 2018	SELL	$51.25 - $76.62 $463,658 - $693,181	-9,047 Reduced 12.24%	64,838 $0
Q1 2018 May 14, 2018	BUY	$52.16 - $66.86 $127,061 - $162,870	2,436 Added 3.41%	73,885 $3.89 Million
Q4 2017 Feb 13, 2018	SELL	$49.6 - $60.87 $74,598 - $91,548	-1,504 Reduced 2.06%	71,449 $3.82 Million
Q3 2017 Nov 02, 2017	BUY	$46.62 - $60.36 $3.4 Million - $4.4 Million	72,953	72,953 $4.35 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account